Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits
Abstract Background Despite inconsistent findings, accumulative evidence has shown abnormalities of the key antioxidant enzyme, superoxide dismutase (SOD), in patients with schizophrenia. However, few studies explored SOD in late-life schizophrenia (LLS). Our work aimed to investigate changes in SOD...
Enregistré dans:
Auteurs principaux: | Lijuan Huo, Xiaobing Lu, Fengchun Wu, Catherine Chang, Yuping Ning, Xiang Yang Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f39b38a2199c41218b67b24944a6e6c2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
par: Aleksandr M. Reznik, et autres
Publié: (2020) -
Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
par: Octavian Vasiliu
Publié: (2021) -
Online Left-Hemispheric In-Phase Frontoparietal Theta tACS for the Treatment of Negative Symptoms of Schizophrenia
par: Chuan-Chia Chang, et autres
Publié: (2021) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
par: Aubel T
Publié: (2021) -
Influence of CFH gene on symptom severity of schizophrenia
par: Zhang C, et autres
Publié: (2017)